Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 17 September 2020


COVID-19 vaccines: Why safety always comes first

Nathalie Moll for Euractiv

With the eyes of the world focused on the development of COVID-19 vaccines to address the devastating health and economic consequences of this truly global pandemic, the news that clinical trials of one of the candidate vaccines had been halted may have caused hearts to sink.

In reality, it underlined the priority commitment to the safety of everyone involved in fighting the coronavirus.

In short it showed that the system is working.

Read more


Our latest statements


Vaccines Europe Statement on the safety of COVID-19 vaccines
17 September 2020

The health and safety of people receiving any vaccine is our first priority, and that applies equally to recipients... Read more

Joint statement of European Pharmaceutical Industry Associations on the European Parliament’s...
17 September 2020

We are committed to continuing to work with the European institutions and other stakeholders to deliver tangible progress... Read more

EFPIA Statement on the State of the Union Address
16 September 2020

The COVID-19 crisis has underlined the importance of Europe’s health research eco-system, our resilience to health threats,... Read more


19 Conversations | The EFPIA podcast series


World Patient Safety Day


Will COVID-19 vaccines be safe?
Across the World, pharmaceutical companies and regulatory agencies are joining forces to find a safe and effective COVID-19... Read more

Can you make enough COVID-19 vaccine to supply the whole world?
We’re working at an unprecedented rate, whilst ensuring we never compromise when it comes to safety. Read more




Understand diabetes, rethink diabetes, share solutions
18 September 2020 (Virtual event)

Are we doing the best we can for the 60 million Europeans living with diabetes? Read more

Every day counts
21 September 2020 (Virtual event)

Accelerate access. Beat cancer. Read more

Oncology Virtual Partnering
22 September 2020 (Virtual event)

Where the best science in oncology comes to meet Read more

How can the EU establish global leadership through an ambitious trade policy?
24 September 2020 (Virtual event)

Join us to debate on what the best way forward for EU Trade policy can be Read more

Neurological diseases: Lessons learnt from COVID and the future of neuroscience
28 September 2020 (Virtual event)

EFNA, EFPIA and EBC are delighted to invite you to join this virtual event. Read more

Clinical Trials Europe
02 November 2020 (Virtual event)

Secure a free pass* to Europe’s largest event dedicated to streamlining clinical trials and improving patient outcomes... Read more


What we are reading


UK’s MHRA allows restart of Oxford/AstraZeneca Covid-19 vaccine trials
On 14 September 2020 (ClinicalTrials)

The Medicines Health Regulatory Authority (MHRA) in the UK has said that the clinical trials of the Oxford/AstraZeneca... Read more

Europe’s health after COVID-19
On 14 September 2020 (Euractiv)

For many stakeholders, this public health crisis has helped Europe learn some lessons and the challenge now is... Read more

EHDEN launches its 3rd open call for data partners!
On 15 September 2020 (EHDEN website)

The current open call will run from September 15 to October 13 2020 Read more